Ultralife (ULBI) to Announce Earnings on Friday

Ultralife (NASDAQ:ULBI) is projected to announce its Q2 2026 results before the market opens on Friday, August 7th. Analysts expect Ultralife to post earnings of $0.19 per share and revenue of $55.00 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Friday, August 7, 2026 at 8:00 AM ET.

Ultralife (NASDAQ:ULBI) last released its quarterly earnings data on Friday, May 8th. The technology company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.15 by ($0.18). Ultralife had a positive return on equity of 1.15% and a negative net margin of 4.37%.The business had revenue of $47.45 million during the quarter, compared to analysts’ expectations of $52.40 million.

Ultralife Price Performance

Shares of NASDAQ ULBI traded up $0.20 on Monday, hitting $5.39. The company’s stock had a trading volume of 7,160 shares, compared to its average volume of 43,091. The stock has a 50 day moving average of $6.18 and a 200-day moving average of $6.37. The company has a market capitalization of $89.80 million, a price-to-earnings ratio of -10.78 and a beta of 0.80. Ultralife has a 12-month low of $4.90 and a 12-month high of $8.72. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.56 and a quick ratio of 1.23.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered shares of Ultralife from a “sell (d+)” rating to a “sell (d)” rating in a research report on Friday, June 12th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Ultralife presently has an average rating of “Sell”.

Insider Activity at Ultralife

In related news, Director Bradford T. Whitmore acquired 67,302 shares of the business’s stock in a transaction dated Tuesday, May 26th. The shares were acquired at an average cost of $6.81 per share, for a total transaction of $458,326.62. Following the acquisition, the director directly owned 2,050,637 shares in the company, valued at approximately $13,964,837.97. The trade was a 3.39% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last three months, insiders have bought 108,878 shares of company stock worth $714,928. Corporate insiders own 42.90% of the company’s stock.

Hedge Funds Weigh In On Ultralife

Large investors have recently modified their holdings of the company. Empowered Funds LLC purchased a new position in shares of Ultralife in the 4th quarter valued at $44,000. XTX Topco Ltd boosted its position in Ultralife by 19.9% during the 4th quarter. XTX Topco Ltd now owns 15,456 shares of the technology company’s stock worth $88,000 after purchasing an additional 2,569 shares during the period. Rothschild Wealth LLC acquired a new stake in Ultralife in the 4th quarter valued at $400,000. Heron Bay Capital Management acquired a new stake in Ultralife in the 4th quarter valued at $127,000. Finally, Jane Street Group LLC purchased a new position in Ultralife in the fourth quarter valued at about $75,000. 30.68% of the stock is currently owned by hedge funds and other institutional investors.

Ultralife Company Profile

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.